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Sir,  6 
Extended-spectrum ß-lactamase (ESBL) producers have become widely disseminated, 7 
particularly in Asia [1]. After a four-week stay in India, a husband and wife (53 and 52 years 8 
old, respectively) were concerned about possible exposure to resistant bacteria. Both were 9 
healthy, without histories of hospitalization or antimicrobial therapies and had not 10 
experienced gastrointestinal symptoms. Faecal swabs were taken for microbiological analysis 11 
using a commercial rectal swab tube containing Amies transport medium (Copan, Brescia, 12 
Italy). Culture of the husband’s sample yielded ESBL producing Enterobacteriaceae (ESBL-13 
ENT) and his wife tested negative. Over the next five months the husband’s faecal swabs 14 
were cultured at intervals of one week, two weeks, one month, 1.5 months, 2.5 months and 15 
five months, each giving rise to ESBL-ENT. A faecal sample obtained after eight months 16 
tested negative, as did two follow-up samples taken at intervals of two and five weeks after 17 
clearance, respectively. 18 
All isolates belonged to the virulent extraintestinal E. coli clone B2:ST127, harboured blaCTX-19 
M-15, and revealed the same PFGE pattern. One of the isolates was tested for six markers of 20 
virulence associated with uropathogenic E. coli (UPEC) (traT, fyuA, PAI, chuA, yfcv, vat) and 21 
eight marker genes of virulence associated with intestinal pathogenic E. coli (IPEC) (aggR 22 
(EAAC), eae (EPEC), STh, STp and LT (ETEC), stx1 and stx2 (STEC) and ipaH (EIEC)). 23 
The isolate tested positive by PCR for five of the six virulence factors that predict 24 
uropathogenicity (fyuA, chuA, PAI, yfcv, vat) but none of the virulence factors for IPEC. 25 
Mating experiments and PCR based plasmid replicon typing (PBRT) yielded negative results 26 
for all isolates, suggesting absence of a plasmid. Southern blot hybridization provided 27 
 2 
evidence for chromosomal location of blaCTX-M-15. Full genome sequencing of the first isolate 28 
(K-14KW52) revealed a chromosomally encoded blaCTX-M-15 gene embedded at the right-hand 29 
extremity of an ISEcp1 element in a plasmid-like structure [2]. All isolates exhibited 30 
resistance to ampicillin, cephalotin, cefotaxime, streptomycin, kanamycin and 31 
sulfamethoxazole. All except one were resistant to gentamicin.  32 
CTX-M-producing isolates have become endemic during the past decade, particularly in the 33 
community setting. This expansion is associated predominantly with the plasmid-mediated 34 
horizontal transfer of blaCTX-M genes [1] and with the spread of specific resistant clones, in 35 
particular of E. coli B2:ST131. Other multidrug resistant enterobacterial lineages of clinical 36 
importance include virulent extraintestinal clones belonging to phylogenetic group D such as 37 
sequence types ST38 and ST405 which are associated with blaCTX-M genes. By contrast, 38 
B2:ST127 has to date not been associated with an ESBL phenotype or with multidrug 39 
resistance [3]. However, it has recently been described as an emerging clone with an 40 
extremely high uropathogenic potential [4] and has been associated with community-acquired 41 
urinary tract infections (CAUTI) in Great Britain [3]. The detection of uropathogenic E. coli 42 
B2:ST127 harbouring blaCTX-M-15 in a healthy person is unusual and a matter of concern, since 43 
UPEC spread easily via person-to-person contact or feco-oral transmission [5]. Notably, 44 
neither the carrier nor his wife developed symptoms of infection during the time under 45 
observation. This report is one of few that describes chromosomal location of blaCTX-M-15 in E. 46 
coli. However, further work is necessary to assess the genetic environment of this 47 
chromosomal gene in E. coli B2:ST127 isolates. 48 
Our data show that this clone can persist for at least five months in the gastrointestinal tract of 49 
a healthy individual. Prolonged carriage and shedding by asymptomatic carriers as illustrated 50 
by this case, may contribute to the dissemination of this clone.  51 
Further studies are needed in order to assess the proportion of B2:ST127(CTX-M-15) isolates 52 
causing community acquired infections such as UTI.	   Increased surveillance of this clone is 53 
justified in order to limit future treatment failures. 54 
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